In millions, except per share items | Dec-31-19 | Dec-31-18 | Dec-31-17 | Dec-31-16 | Dec-31-15 | Dec-31-14 | Dec-31-13 | Dec-31-12 |
| 10-K | 10-K | 10-K | 10-K | 10-K | 10-K | 10-K | 10-K |
Interest income: |
Interest income on loans | 73.6 | 68.5 | 51.2 | 46.8 | 44.2 | 43.5 | 44.0 | 46.1 |
Interest income on investments | 10.7 | 10.4 | 7.0 | 6.5 | 7.1 | 7.0 | 7.1 | 8.8 |
| 85.3 | 79.7 | 58.9 | 53.8 | 51.8 | 51.2 | 51.7 | 55.3 |
Interest expense: |
Interest on deposits | 15.1 | 10.9 | 6.8 | 5.3 | 5.3 | 6.1 | 9.3 | 11.8 |
Interest on borrowings | 5.0 | 4.9 | 3.6 | 3.6 | 3.1 | 2.2 | 1.3 | 2.1 |
| 21.0 | 16.6 | 10.6 | 9.2 | 8.8 | 8.9 | 11.2 | 14.7 |
Net interest income | 64.3 | 63.1 | 48.3 | 44.6 | 43.0 | 42.3 | 40.4 | 40.6 |
Provision for loan losses | 2.0 | 2.1 | 1.2 | 0.9 | 0.1 | 0.9 | 1.3 | 6.0 |
Net interest income after provision for loan losses | 62.3 | 61.0 | 47.0 | 43.7 | 42.8 | 41.4 | 39.1 | 34.6 |
Deposit and loan fees | | | | 6.1 | 5.9 | 6.0 | 6.0 | 6.5 |
Gain on sale of investments, net | | | | 1.0 | 0.4 | 0.3 | 0.8 | 2.8 |
Other non-interest income | 24.9 | 19.6 | 18.1 | 12.3 | 10.8 | 8.6 | 7.2 | 23.0 |
Total non-interest income | 24.9 | 19.6 | 18.1 | 19.4 | 17.1 | 14.9 | 14.1 | 32.3 |
Non-interest expenses | 61.2 | 58.7 | 46.0 | 45.5 | 43.1 | 41.4 | 39.7 | 40.3 |
Equity in earnings | | | | | | | | -0.5 |
Pre-tax income | 26.1 | 21.8 | 19.1 | 17.6 | 16.8 | 14.9 | 13.5 | 9.9 |
Income taxes | 2.4 | 3.0 | 6.8 | 4.4 | 4.6 | 3.9 | 4.1 | 2.6 |
Tax rate | 9.0% | 13.6% | 35.6% | 24.9% | 27.2% | 25.9% | 30.6% | 26.6% |
Net income | 23.8 | 18.9 | 12.3 | 13.2 | 12.3 | 11.0 | 8.1 | 5.8 |
Net margin | 27.2% | 23.4% | 18.9% | 21.0% | 20.4% | 19.6% | 15.3% | 8.7% |
|
Basic EPS | $2.77 | $2.25 | $1.67 | $1.79 | $1.66 | $1.54 | $1.15 | $0.83 |
Diluted EPS | $2.74 | $2.21 | $1.64 | $1.76 | $1.62 | $1.49 | $1.12 | $0.82 |
|
Shares outstanding (basic) | 8.6 | 8.4 | 7.4 | 7.4 | 7.4 | 7.2 | 7.1 | 7.0 |
Shares outstanding (diluted) | 8.7 | 8.5 | 7.5 | 7.5 | 7.5 | 7.4 | 7.3 | 7.1 |
|
EBIT is a non-GAAP figure that excludes all non-recurring expenses: restructuring costs, asset impairments, IPR&D writeoffs, and other unusual charges. |